Navier Medical
PrivateLast Round
Early Funding
Jun 30, 2025
Total Funding Raised
$2.06M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Navier Medical operates in Healthcare & Life Sciences and is based in Perth. Its latest recorded funding round was an Early Funding round in June 2025.
Navier Medical is a medical technology company that develops AI-powered software for the analysis of cardiovascular imaging to improve the detection and treatment of heart disease.
Sector
Healthcare & Life Sciences
Verticals
Medical Imaging, Medical AI, Medical Devices, Healthcare Analytics
Business Model
B2B
Customer Profile
Subscription SaaS
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Navier Medical Comparables
Compare Navier Medical with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Artrya Ltd | 84% | |
| Caristo Diagnostics | 83% | |
| Circle Cardiovascular Imaging | 78% |
For institutional investors. Book with your work email.
Navier Medical Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Early Funding | Jun 30, 2025 | ||||
| Grant | Mar 1, 2025 | ||||
| Grant | Dec 1, 2024 | ||||
| Grant | Jun 28, 2023 | ||||
| Seed | Jun 30, 2022 | ||||
Grant | Nov 3, 2021 |
For institutional investors. Book with your work email.
Navier Medical Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| New Industries and Innovation Fund | Grant |
| Government of Western Australia | Grant |
| ANDHealth | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 22, 2026
Monthly visitors grew 35% MoM, from 911 to 1.2K.
- Aug 10, 2026
Open roles increased from 0 to 2, representing 22% of headcount.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- receives_financingAug 14, 2026
Navier Medical Ltd receives $1.5M in non-dilutive CUREator+ financing in Australia to develop AI-enabled cardiac CT risk markers that support earlier prediction and prevention of heart attacks, prospective clinical trials, platform development and commercial readiness.
For institutional investors. Book with your work email.
Navier Medical Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Navier Medical's valuation, stock price, and market status.
Is Navier Medical a public or private company?
Navier Medical is a private company.
What is the current stock price of Navier Medical?
Navier Medical is a private company, so its shares have no public market price. Caplight tracks Navier Medical's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Navier Medical worth (valuation)?
Valuation information for Navier Medical is not publicly available.
Can I buy Navier Medical stock?
Navier Medical shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Navier Medical's last funding round?
Navier Medical's most recent funding round was Early Funding on June 30, 2025.
Who are the main investors in Navier Medical?
Key investors in Navier Medical include New Industries and Innovation Fund, Government of Western Australia, ANDHealth.
Will Navier Medical IPO soon?
No public IPO plans have been announced for Navier Medical.
How can I track Navier Medical secondary market activity?
Caplight tracks bids, offers, and trades in Navier Medical's shares on secondary markets.